Mitochondria in Ischemic Stroke: New Insight and Implications.
Liu F, Lu J, Manaenko A, Tang J, Hu Q. · 2018
Read Mitochondria in Ischemic Stroke: New Insight and Implications. by Liu F, Lu J, Manaenko A, Tang J, Hu Q. (2018) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6147588.txt.
Introduction
Liu and co-authors wrote a review in Aging and Disease on mitochondria in ischemic stroke. Stroke is a leading cause of death and adult disability worldwide. Most strokes are ischemic, meaning a blocked vessel starves brain tissue. Failure of mitochondria, the cell's power plants, is a hallmark of the damage that follows.
The review covers how mitochondria behave during blocked blood flow and its return. It focuses on quality control, the systems that repair or remove damaged mitochondria. New findings on mitochondria moving between cells also feature. Keeping these power plants working may help neurons survive. The authors highlight mitochondria as targets for future stroke treatment.
Catalog record
| CREATOR | Liu F, Lu J, Manaenko A, Tang J, Hu Q. |
|---|---|
| YEAR | 2018 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 58 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Mitochondria in Ischemic Stroke: New Insight and Implications By Fan Liu, Jianfei Lu, Anatol Manaenko, Junjia Tang, Qin Hu Published in: Aging and Disease DOI: 10.14336/AD.2017.1126 ABSTRACT Stroke is the leading cause of death and adult disability worldwide. Mitochondrial dysfunction has been regarded as one of the hallmarks of ischemia/reperfusion (I/R) induced neuronal death. Maintaining the function of mitochondria is crucial in promoting neuron survival and neurological improvement. In this article, we review current progress regarding the roles of mitochondria in the pathological process of cerebral I/R injury. In particular, we emphasize on the most critical mechanisms responsible for mitochondrial quality control, as well as the recent findings on mitochondrial transfer in acute stroke. We highlight the potential of mitochondria as therapeutic targets for stroke treatment and provide valuable insights for clinical strategies. 1. INTRODUCTION Stroke is one of the leading causes of morbidity and mortality worldwide. More than 80% of strokes are ischemic and are caused by obstruction of one or more cerebral arteries [1, 2]. Lack of blood supply deprives the brain cells of necessary glucose and oxygen, and disturbs cellular homeostasis, culminating in neuronal death. Currently, tissue plasminogen activator (tPA) is the only effective pharmacological therapy approved by the Food and Drug Administration for acute ischemic stroke since 1996, but its use remains limited due to the narrow therapeutic window [3-6]. It is imperative to develop novel therapeutic strategies of stroke [7, 8]. Mitochondria, as the powerhouse of cell, play a critical role in cell energy homeostasis and are thus inevitably involved in the ischemic neuronal death. After ischemia, due to the reduced blood supply, the energy balance is disrupted and adenosine triphosphate (ATP) synthesis is disturbed. In addition to their fundamental role in energy generation, mitochondria are critical involved in the regulation of such forms of cell death as apoptosis, autophagy and necroptosis. Mitochondrial dysfunction has been regarded as one of the hallmarks of ischemia/reperfusion (I/R) injury which induces neuronal death[9]. Accumulating evidences indicate that the maintaining of the mitochondrial function is crucial for neuron survival and neurological improvement. Therefore, targeting mitochondria is one of the promising neuroprotective strategies for stroke treatment [10]. Recently, it has been demonstrated that mitochondria can be transferred from astrocytes to neurons and served as “help-me signaling” in cell-to-cell communication after cerebral ischemia [11]. In this review, we will discuss current knowledge on the role of mitochondria in cell death and cell survival, and highlight the advance of mitochondria-based therapy in stroke. In particular, we will emphasize the most critical mechanisms responsible for mitochondrial quality control, as well as the recent findings on mitochondrial transfer in acute ischemic stroke. 2. PATHOPHYSIOLOGY OF ISCHEMIC STROKE Ischemic stroke is a consequence of a critical reduction of regional cerebral blood flow (rCBF), leading to severe oxygen and glucose deprivation. Mitochondrial disfunction induced by oxygen and glucose deprivation occurs within minutes after ischemia, resulting in depletion of ATP production and overproduction of reactive oxidative species (ROS). Compared to other brain cells, neurons have higher energy demand, but their energy reserves are limited. Depletion of ATP is one of the major initiator, which triggers the ischemic cascades such as, membrane ion pump failure, efflux of cellular potassium, influx of sodium, chloride and water, and membrane depolarization [12-14]. Multiple mechanisms, including excitotoxicity, mitochondrial response, free radical release, acidotoxity, protein misfolding, and inflammation have been extensively studied as the events leading to the cellular death and neuronal loss after stroke [15-17], which are depicted in Fig. 1. Figure 1.Mechanisms underlying neuronal death in ischemic stroke(1) Mitochondrial response, including excessive ROS production, mitochondrial calcium overloading, and disrupted mitochondria quality control. (2) Excitotoxicity. Excessive glutamate release and impeded reuptake of excitatory amino acids result in the activation of NMDARs, AMPARs and KARs. (3) Acidotoxity. Extracellular acidification leads to ischemic neuronal death by activating acid-sensing ion channel 1a (ASIC1a). (4) Protein misfolding. Protein misfolding and aggregation are observed after brain ischemia. (5) Inflammatory reaction. Microglia are activated and release cytokines and chemokines to induce inflammation reaction. All the factors mentioned above work synergistically to trigger cell death pathways such as apoptosis, necroptosis and autophagy. ROS: reactive oxygen species; AMPAR: α-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid receptor; NMDAR: N-methyl-D-aspartate receptor; KAR: kainite receptor; DAPK1: death associated protein kinase 1; PSD95: postsynaptic density protein 95; ASIC1a: acid-sensing ion channel 1a; RIPK1: receptor interacting protein kinase 1; TNF-α: tumor necrosis factor-α; IL-6: Interleukin 6; IL-1: Interleukin 1. [Table: Mitochondrial dynamic-related proteins.] There are two major zones of injury in ischemic brain: the infarct core and the ischemic penumbra. The “infarct core” is the area with the blood flow decline below the threshold of energy failure (15%-20%). The “infarct core” will be irreversibly damaged during few minutes after stroke and cannot be salvaged [18]. On the contrary, ischemic penumbra is the region with impaired functions, but preserved structure integrity [19]. Cells in penumbra are salvageable if reperfusion is established during the early hours or collateral circulation is adequate to maintain the neuronal demand for oxygen and glucose [15]. Therefore, the penumbra is the pharmacological target for the treatment of acute ischemic stroke. In the infarct core, neuronal cells undergo necrotic alterations, which are accompanied by glutamate release and excitotoxic cell damage to neighboring regions [20]. The penumbra is moderately hypoperfused and energy metabolism is partially preserved, which transiently sustain tissue viability. Timely interventions are effective to avoid the progression of the penumbra into infarction. The molecular mechanisms leading to the cell death in the penumbra differ from those in the infarct area. Several types of regulated cell death such as autophagy, apoptosis, necroptosis, and pyroptosis can be triggered by ischemia and contribute to the post stroke brain injury. To some extent, different kind of cell death can cross-regulate each other [21, 22]. Mitochondria can be considered as one of the master regulators of stress signaling [23-26] (Fig. 2). The impairment of mitochondrial respiratory function and membrane potential activate the cascade of events that leads to neuronal death after ischemia. Depolarized mitochondria initiate excessive ROS production, decreased ATP generation, PTEN-induced putative kinase 1 (PINK1) accumulation, as well as unfolded protein response (UPR) [27]. The increased levels of ROS and overloading calcium open the membrane permeability transition pore allowing for the release of cytochrome c, which activates the effector caspases and the final execution of apoptotic death [28]. PINK1 selectively recruits Parkin and phosphorylates both Parkin and ubiquitin to trigger mitophagy [29]. Interruption of the signaling pathways is apparently able to disrupt, or in some instances greatly delay, the spiral of increasingly vicious reactions that culminate in cell death. Figure 2.Mitochondria play a central role in ischemic neuronal deathIschemia triggers the depolarization of mitochondrial membrane potential (ΔΨm), reduction of ATP production, accumulation of PINK1, recruitment of Parkin, overproduction of reactive oxygen species (ROS), overloading of matrix calcium, and opening of mitochondrial permeability transition pore (mPTP), eventually leading to neuronal death. 3. STRUCTURE AND FUNCTION OF MITOCHONDRIA Mitochondria are ovoid or rod-shaped organelles with double-membrane structure, which consist of four distinct compartments - the outer membrane, the intermembrane space, the inner membrane, and the matrix [30]. The outer membrane contains a number of pores which form large aqueous channels to permit free diffusion of molecules less than 5000 daltons into the intermembrane